Company news
Owc Pharmaceutical Research Corp news in 2016
Owc Pharmaceutical Research Corp's news releases, calls and decks from 2016, newest first.
OWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event
November 18, 2016
OWC Pharmaceutical Research Corp to Submit Psoriasis Topical Cream IRB Safety Protocol to the Israeli National IRB ("Helsinki") Committee
November 15, 2016
OWC Pharmaceutical Corporation Advisory Board Member, Jeffrey Friedland, Comments on the Election and the Possible Impact on the U.S. Cannabis Market
November 7, 2016
OWC Pharmaceutical Research Corp Signs Investment and Joint Venture with Michepro Holdings Ltd
November 3, 2016
New Colombia Resources Inc to Produce Infomercials to Sell All Natural 100% Organic Cannabis Based Products from Colombia to the U.S. Hispanic and Latin American Markets
October 21, 2016
OWC Pharmaceutical Research Corp Completes Development of Its Medical Cannabis Sublingual Tablet
October 20, 2016
OWC Pharmaceutical Research Corp to Initiate Efficacy Testing on its Cannabinoid-Infused Cream for Treatment of Psoriasis
October 11, 2016
OWC Pharmaceutical Research Corp Signs Agreement With US Partner for Funding in Advance of Future Royalties
September 30, 2016
OWC Pharmaceuticals Corp to Present at Israeli Advanced Technology Industry's BioMed Conference
April 26, 2016
OWC Pharmaceutical Comments on Israel's Proposed Medical Cannabis Guidelines
April 12, 2016
OWC Pharmaceutical Research Advances Its Multiple Myeloma Study to Animals
March 29, 2016
Jeffrey Friedland Joins OWC Pharmaceutical Research's Advisory Board
March 15, 2016
OWC Pharmaceutical Research Corp Completes Formulation of Cannabinoid-Infused Topical Cream
March 9, 2016
OWC Pharmaceutical Research Corp. Issues Letter to Shareholders
February 16, 2016
OWC Pharmaceutical Research Announces $750K Equity Purchase Agreement With Kodiak Capital Group
January 11, 2016